Skip to main content

Archived Comments for: Usefulness of electronic databases for the detection of unrecognized diabetic patients

Back to article

  1. Pivotal role of Biophysical Semeiotic Constitutions in Primary Prevention

    Sergio Stagnaro, Private

    8 January 2004

    Sirs, in accordance with the authors of an interesting article (1), diabetes is a major problem worldwide and a large number of patients remain unrecognized. During the recent decades diabetes prevalence has increased rapidly among both developed and underdeveloped populations. Surely, genetic factors alone cannot explain these patterns. However, as a 46-year clinical experience allows me to state, (See in HONCode site 233736, URL: www.semeioticabiofisica/constitutions.htm) an individual without “diabetic AND dyslipidemic biophysical-semeiotic constitutions”,cannot be affected by type 2 diabetes at all. Certainly, rapid changes in lifestyle and risk factors such as obesity, unhealthy diets, physical inactivity, tobacco smoking, acting on people with “diabetic and dyslipidemic constitution” may cause, first, type 2 diabetes. In a few words, the war against diabetes mellitus and its well-known and harmful complications, as well as the war against all other serious and common human diseases, is nowadays possible around the world, exclusively by means of a primary prevention. This must be achieved at the bed-side, i.e., "clinically", on a very large scale, using the simple stethoscope. In other words, in every screening program for a given disease, including DM and its complications and cancer, one needs efficacious "clinical" tools to obtain the best results. Really, early diagnosis must certainly be established in "asymptomatic" patients, who, for example, are evolving slowly towards diabetes mellitus - i.e. long time before disease onset - in order to avoid the well known, severe complications. In fact, to prevent these diabetic complications, including diabetic retinopathy, it is extremely necessary that doctors use a "clinical" tool reliable in diagnosing early diabetes mellitus from its initial stages, i.e., biophysical-semeiotic constitutions, and then the Pre-Metabolic Syndrome (See, URL: syndrome engl.doc) (1, 2, 3, 5, ).

    1) Shlomo Vinker , Yaacov Fogelman , Asher Elhayany , Sasson Nakar and Ernesto Kahan

    Usefulness of electronic databases for the detection of unrecognized diabetic patients. Cardiovasc Diabetol 2003, 2:13

    2) Stagnaro S., Istangiopatia Congenita Acidosica Enzimo-Metabolica condizione necessaria non sufficiente della oncogenesi. XI Congr. Naz. Soc. It. di Microangiologia e Microcircolaz. Abstracts, pg 38, 28 Settembre-1 Ottobre, 1983, Bellagio

    3) Stagnaro S., Istangiopatia Congenita Acidosica Enzimo-Metabolica. X Congr. Naz. Soc. It. di Microangiologia e Microcircolazione. Atti, 61. 6-7 Novembre, 1981, Siena

    4) Stagnaro S., Istangiopatia Congenita Acidosica Enzimo-Metabolica. Una Patologia Mitocondriale Ignorata. Gazz Med. It. - Arch. Sci. Med. 144, 423, 1985 (Infotrieve).

    5) Stagnaro S., Diet and Risk of Type 2 Diabetes. N Engl J Med. 2002 Jan 24;346(4):297-298. letter [PubMed –indexed for MEDLINE].

    Competing interests

    No declare